DiSalvo Wendye M, Joyce Margaret M, Tyson Leslie B, Culkin Ann E, Mackay Kathleen
Norris Cotton Cancer Center, Dartmouth Hitchcock Medical Center, Lebanon, NH, USA.
Clin J Oncol Nurs. 2008 Apr;12(2):341-52. doi: 10.1188/08.CJON.341-352.
Despite the common occurrence of cancer-related dyspnea, a paucity of literature is available for review, especially research literature that reports interventions to control dyspnea. The Oncology Nursing Society's Putting Evidence Into Practice (PEP) initiative organized a team on nurses to examine the literature, rank the evidence, summarize the findings, and make recommendations for nursing practice to improve patient outcomes. Pharmacologic and nonpharmacologic agents have been used to treat dyspnea. Patients who received parenteral or oral immediate-release opioids demonstrated a benefit in the reduction of breathlessness; thus, parenteral or oral opioids are recommended for practice. Five interventions are listed in the effectiveness not established category and include extended-release morphine, midazolam plus morphine, nebulized opioids, the use of gas mixtures, and cognitive-behavioral therapy. This article critically examines the evidence, provides nurses with the best evidence for practice, and identifies gaps in the literature and opportunities for further research.
尽管癌症相关性呼吸困难很常见,但可供综述的文献却很少,尤其是报告控制呼吸困难干预措施的研究文献。肿瘤护理学会的“将证据应用于实践”(PEP)倡议组织了一个护士团队来审查文献、对证据进行排名、总结研究结果,并为护理实践提出建议以改善患者结局。药物和非药物制剂已用于治疗呼吸困难。接受胃肠外或口服即释阿片类药物的患者在减轻呼吸急促方面显示出益处;因此,推荐胃肠外或口服阿片类药物用于实践。有五项干预措施被列为有效性未确定类别,包括缓释吗啡、咪达唑仑加吗啡、雾化阿片类药物、气体混合物的使用以及认知行为疗法。本文批判性地审查了证据,为护士提供了最佳实践证据,并确定了文献中的空白以及进一步研究的机会。